Bolt Biotherapeutics (BOLT) Price to Sales (2021 - 2026)
Bolt Biotherapeutics' (BOLT) Price to Sales came in at 1.58 for Q2 2026, down 40.6% from 2.66 a year earlier but up 32.1% from the prior quarter.
Powered by 
Analysis
Bolt Biotherapeutics (BOLT) Price to Sales (2021 - 2026) Analysis & Trends
For FY2025, Bolt Biotherapeutics' Price to Sales stood at 1.37, down 48.8% from FY2024.
- Annual Price to Sales has declined for four consecutive years.
- In prior years, Bolt Biotherapeutics' Price to Sales was 2.67 in FY2024 (-50.8%), 5.42 in FY2023 (-36.8%), 8.58 in FY2022 (-94.1%) and 145.44 in FY2021.
- Quarterly Price to Sales has run from a low of 1.19 in Q1 2026 to a high of 626.58 in Q3 2021 over five years.
- On a year-over-year basis, Price to Sales has declined in each of the last four quarters, with an average decline of 36.9% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q2 2025, with growth of 3.4%; the weakest was Q2 2022, with a decline of 99.7%.
- According to Business Quant data, Price to Sales for the three prior quarters was 1.19 (Q1 2026), 1.37 (Q4 2025) and 1.97 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Bolt Biotherapeutics | 6.70 Mn | 6.70 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.58 |
| Mar 31, 2026 | 1.19 |
| Dec 31, 2025 | 1.37 |
| Sep 30, 2025 | 1.97 |
| Jun 30, 2025 | 2.66 |
| Mar 31, 2025 | 4.22 |
| Dec 31, 2024 | 2.67 |
| Sep 30, 2024 | 2.54 |
| Jun 30, 2024 | 2.57 |
| Mar 31, 2024 | 4.71 |
| Dec 31, 2023 | 5.42 |
| Sep 30, 2023 | 5.49 |
| Jun 30, 2023 | 7.16 |
| Mar 31, 2023 | 7.80 |
| Dec 31, 2022 | 8.58 |
| Sep 30, 2022 | 11.55 |
| Jun 30, 2022 | 22.15 |
| Mar 31, 2022 | 49.53 |
| Dec 31, 2021 | 145.44 |
| Sep 30, 2021 | 626.58 |
API Access
Bolt Biotherapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();